Scholars Central

Conference abstract

Development of Vero cell-based influenza H5N1 vaccines

Authors: Min Shi Lee

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

C urrent egg-based influenza vaccine production technology is labor-intensive and lack of flexibility. Moreover, its capacity would not be able to meet the demand during influenza pandemics. This was illustrated in the 2009 H1N1 pandemic where only 22% of expected doses were supplied within the first 6 months after the pandemic was declared. Therefore, cell-based technology is becoming attractive for production of pandemic influenza vaccines. Two cell lines, MDCK and Vero cells are currently used for manufacturing human influenza vaccines. MDCK cells can only be used for manufacturing influenza vaccines. In contrast, Vero cells have been widely used for the production of human vaccines. The current WHO-recommended influenza H5N1 clade-1 vaccine strain (NIBRG-14), a reassortant virus between A/Vietnam/1194/2004 (H5N1) virus and egg-adapted high-growth A/PR/8/1934 virus, could grow efficiently in eggs and MDCK cells but not Vero cells. Therefore, we first adapted the egg-derived NIBRG-14 in Vero cells to become a Vero cell-adapted high-growth H5N1 vaccine virus (Vero-15), which could reach high virus titer (>10 8 TCID50/ml) in Vero cells in multiple culture systems including T flasks, mirocarriers and TideCell cultures. Then, we established reverse genetics platform to generate high-growth reassortant H5N1 clade-2 viruses using the Vero-15 virus as a master donor virus. In conclusion, the Vero-15 H5N1 vaccine virus has the commercial potential to become a seed virus for manufacturing H5N1 vaccines. In addition, the Vero-15 H5N1 vaccine virus could become a mater donor virus to generate seed viruses for other influenza A subtypes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Min Shi Lee”